Table of Contents
France Cardiovascular Prosthetic Procedures Outlook to 2020
GlobalData’s new report, "France Cardiovascular Prosthetic Procedures Outlook to 2020", provides key procedures data on the France Cardiovascular Prosthetic Procedures. The report provides procedure volumes within market category - Septal Occluder Procedures (Atrial Septal Defect (ASD) Occluder, Ventricular Septal Defect (VSD) Occluder and Patent Foramen Ovale (PFO) Occluder Procedures).
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
- Procedure volumes data for Cardiovascular Prosthetic Procedures market category - Septal Occluder Procedures (Atrial Septal Defect (ASD) Occluder, Ventricular Septal Defect (VSD) Occluder and Patent Foramen Ovale (PFO) Occluder Procedures).
- Projections for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
Reasons to buy
- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential Summary Immunology is a large therapy area characterized by disorders of ...
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation Summary Head and neck cancer (HNC) is the sixth most common malignancy worldwide, ...
“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. ...